Patients seem to like remote visits, and health care providers now depend on them. But outages, freezing and other glitches cost time and money, and compromise quality of care.
Because there are no caps on cost, consumers and insurers often get billed hundreds of dollars for the most reliable PCR covid test. Prices are rising and they can’t fight back.
Over-the-counter covid tests could help speed the economy’s recovery, allowing students and workers to test themselves at home and get quick results. Could they become as ubiquitous as toothpaste and cold remedies on store shelves, or will demand dry up as the nation gets vaccinated?
In rural Alpine County, where snowbound mountain passes isolate small towns, distributing the covid vaccine is a community effort. Unlike in many urban areas where residents jockey for limited appointments, the pace of vaccinations here is strong and steady.
COVID-19 cases are surging across the U.S., and most workplaces are still open for business. As workers fear catching the disease while on the clock, why aren’t more companies footing the bill for testing employees?
A case study of COVID-19 testing in Sacramento, California, shows that bottlenecks in the testing supply chain this summer limited people’s access to tests and dramatically delayed results. Similar scenarios played out in communities across the country.
Cancer patients seeking care during the coronavirus pandemic face an array of obstacles as states reopen, such as heavily restricted in-hospital appointments and new clinical trials on hold.
KHN’s Shefali Luthra examines the president’s talking points on a range of topics — from insurance coverage, access to care and affordability issues to preexisting condition protections and prescription drug costs.
In our ongoing, crowdsourced investigation with NPR and CBS, we’ve armed future health system pilgrims with the tools they need to avoid exorbitant medical bills and fight back against unfair charges. Here’s a look back at 2019’s stories.